沃特股份(002886.SZ):公司PEEK樹脂合成項目試生產週期已滿,相關設備運轉達到設計要求
格隆匯5月7日丨沃特股份(002886.SZ)在投資者關係表示,公司PEEK樹脂合成項目試生產週期已滿,相關設備運轉達到設計要求,項目已通過相關主管部門組織的驗收專家評審會評審,正履行相關許可手續待換髮正式生產許可證,公司已就新建產能開展各項客户導入工作。子公司浙江科賽新材料科技有限公司百噸級PEEK型材加工產線完成公司自產PEEK樹脂的認證工作,為公司PEEK材料的推廣提供了新的支撐。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.